3511 - 3520 of 8819 Results
Title
Year
-
RESTRICTEDTitle: Biomarkers for cognitive dysfunction in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: S19End Page: S23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.023Citation Count: 50
-
RESTRICTEDTitle: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 20Issue #: 3Start Page: 419End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.03-1449comCitation Count: 692
-
RESTRICTEDTitle: On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 5Start Page: 876End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29762Best OA location URL: https://lirias.kuleuven.be/retrieve/32b56e2d-a261-47a9-b246-c18fdc3a8147Citation Count: 13
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 176
-
OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 19704End Page: 19704Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 3
-
OPENTitle: Current disease modifying approaches to treat Parkinson’s diseaseJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 73Issue #: 7Start Page: 1365End Page: 1379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11108524Citation Count: 95
-
OPENTitle: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased LigandsJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 11Issue #: 3Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074212Citation Count: 12
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 105
-
OPENTitle: Dual-Task Performance in GBA Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/8582740Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/8582740.pdfCitation Count: 4
-
OPENTitle: Compensatory neural mechanisms in cognitively unimpaired Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 3Start Page: 448End Page: 463Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ndDOI - Digital Object Identifier: 10.1002/ana.24585Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24585Citation Count: 71